302 related articles for article (PubMed ID: 29017518)
21. Reporting of sample size calculation in randomised controlled trials: review.
Charles P; Giraudeau B; Dechartres A; Baron G; Ravaud P
BMJ; 2009 May; 338():b1732. PubMed ID: 19435763
[TBL] [Abstract][Full Text] [Related]
22. Joint distraction for knee osteoarthritis: protocol for a systematic review and meta-analysis.
Goh EL; Lou WCN; Chidambaram S; Ma S
Syst Rev; 2018 Oct; 7(1):162. PubMed ID: 30322405
[TBL] [Abstract][Full Text] [Related]
23. Osteoarthritis.
Dieppe P; Chard J; Lohmander S; Smith C
Clin Evid; 2002 Jun; (7):1071-90. PubMed ID: 12230728
[No Abstract] [Full Text] [Related]
24. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.
Chen J; Li J; Li R; Wang H; Yang J; Xu J; Zha Z
Pain Med; 2017 Feb; 18(2):374-385. PubMed ID: 28034979
[TBL] [Abstract][Full Text] [Related]
25. Hip Strength Deficits in People With Symptomatic Knee Osteoarthritis: A Systematic Review With Meta-analysis.
Deasy M; Leahy E; Semciw AI
J Orthop Sports Phys Ther; 2016 Aug; 46(8):629-39. PubMed ID: 27374011
[TBL] [Abstract][Full Text] [Related]
26. Neuromuscular electrical stimulation in the treatment of knee osteoarthritis: a systematic review and meta-analysis.
Giggins O; Fullen B; Coughlan G
Clin Rehabil; 2012 Oct; 26(10):867-81. PubMed ID: 22324059
[TBL] [Abstract][Full Text] [Related]
27. VASO (Vitamin D and Arthroplasty Surgery Outcomes) study - supplementation of vitamin D deficiency to improve outcomes after total hip or knee replacement: study protocol for a randomised controlled feasibility trial.
Morrison RJM; Bunn D; Gray WK; Baker PN; White C; Rangan A; Rankin KS; Reed MR
Trials; 2017 Nov; 18(1):514. PubMed ID: 29096686
[TBL] [Abstract][Full Text] [Related]
28. Does Cryotherapy Improve Outcomes With Soft Tissue Injury?
Hubbard TJ; Denegar CR
J Athl Train; 2004 Sep; 39(3):278-279. PubMed ID: 15496998
[TBL] [Abstract][Full Text] [Related]
29. Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
Walters SJ; Jacques RM; Dos Anjos Henriques-Cadby IB; Candlish J; Totton N; Xian MTS
Trials; 2019 Sep; 20(1):566. PubMed ID: 31519202
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of culture-expanded, mesenchymal stem/stromal cells for the treatment of knee osteoarthritis: a systematic review protocol.
Harrison-Brown M; Scholes C; Hafsi K; Marenah M; Li J; Hassan F; Maffulli N; Murrell WD
J Orthop Surg Res; 2019 Jan; 14(1):34. PubMed ID: 30683159
[TBL] [Abstract][Full Text] [Related]
31. Validity of sample sizes in publications of randomised controlled trials on the treatment of age-related macular degeneration: cross-sectional evaluation.
Tulka S; Geis B; Baulig C; Knippschild S; Krummenauer F
BMJ Open; 2019 Oct; 9(10):e030312. PubMed ID: 31601589
[TBL] [Abstract][Full Text] [Related]
32. The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review.
Arnup SJ; Forbes AB; Kahan BC; Morgan KE; McDonald S; McKenzie JE
Syst Rev; 2014 Aug; 3():86. PubMed ID: 25115725
[TBL] [Abstract][Full Text] [Related]
33. Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.
Cook JA; Hislop J; Altman DG; Fayers P; Briggs AH; Ramsay CR; Norrie JD; Harvey IM; Buckley B; Fergusson D; Ford I; Vale LD;
Trials; 2015 Jan; 16():12. PubMed ID: 25928502
[TBL] [Abstract][Full Text] [Related]
34. Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review.
McKeown A; Gewandter JS; McDermott MP; Pawlowski JR; Poli JJ; Rothstein D; Farrar JT; Gilron I; Katz NP; Lin AH; Rappaport BA; Rowbotham MC; Turk DC; Dworkin RH; Smith SM
J Pain; 2015 Mar; 16(3):199-206.e1-7. PubMed ID: 25481494
[TBL] [Abstract][Full Text] [Related]
35. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study.
Nüesch E; Trelle S; Reichenbach S; Rutjes AW; Tschannen B; Altman DG; Egger M; Jüni P
BMJ; 2010 Jul; 341():c3515. PubMed ID: 20639294
[TBL] [Abstract][Full Text] [Related]
36. A phase II trial for the efficacy of physiotherapy intervention for early-onset hip osteoarthritis: study protocol for a randomised controlled trial.
Kemp JL; Moore K; Fransen M; Russell TG; Crossley KM
Trials; 2015 Jan; 16():26. PubMed ID: 25622524
[TBL] [Abstract][Full Text] [Related]
37. Manual therapy for osteoarthritis of the hip or knee - a systematic review.
French HP; Brennan A; White B; Cusack T
Man Ther; 2011 Apr; 16(2):109-17. PubMed ID: 21146444
[TBL] [Abstract][Full Text] [Related]
38. Barriers and facilitators to physical activity in people with hip or knee osteoarthritis: protocol for a systematic review of qualitative evidence.
Kanavaki AM; Rushton A; Klocke R; Abhishek A; Duda JL
BMJ Open; 2016 Nov; 6(11):e012049. PubMed ID: 27810971
[TBL] [Abstract][Full Text] [Related]
39. DELTA
Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson ECF; Maclennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD
Trials; 2018 Nov; 19(1):606. PubMed ID: 30400926
[TBL] [Abstract][Full Text] [Related]
40. Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease.
Ethgen M; Boutron I; Baron G; Giraudeau B; Sibilia J; Ravaud P
Ann Intern Med; 2005 Jul; 143(1):20-5. PubMed ID: 15998751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
